RecruitingNCT07355491

Performance Evaluation of Dream OCT: AP Study

Sponsor

Intalight, Inc

Enrollment

120 participants

Start Date

Dec 16, 2025

Study Type

OBSERVATIONAL

Conditions

Glaucoma Patients Retina Patients Eyes With Corneal Abnormality Normal Healthy Eyes

Summary

This study will evaluate the clinical performance of a new swept-source OCT imaging device, the VG200D, and to evaluate substantial equivalence with a predicate device, the Cirrus 5000. Clinical performance will be assessed through an agreement and precision analysis of OCT measurement parameters.

Eligibility

Min Age: 22 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying This is an observational study only, all patients are imaged on the investigational device for people with eyes with corneal abnormality, glaucoma patients, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 22 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEThis is an observational study only, all patients are imaged on the investigational device

This study is a non-significant risk study where enrolled patients are imaged on an investigational device and a predicate device

Locations(1)

Illinois College of Optometry

Chicago, Illinois, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07355491